ZA964680B - Recombinant feline immunodeficiency vaccines produced in baculovirus and their use against feline immunodeficiency virus infection. - Google Patents

Recombinant feline immunodeficiency vaccines produced in baculovirus and their use against feline immunodeficiency virus infection.

Info

Publication number
ZA964680B
ZA964680B ZA9604680A ZA964680A ZA964680B ZA 964680 B ZA964680 B ZA 964680B ZA 9604680 A ZA9604680 A ZA 9604680A ZA 964680 A ZA964680 A ZA 964680A ZA 964680 B ZA964680 B ZA 964680B
Authority
ZA
South Africa
Prior art keywords
feline immunodeficiency
baculovirus
virus infection
use against
vaccines produced
Prior art date
Application number
ZA9604680A
Other languages
English (en)
Inventor
Terri Wasmoen
Hsien-Jue Chu
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of ZA964680B publication Critical patent/ZA964680B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
ZA9604680A 1995-06-07 1996-06-05 Recombinant feline immunodeficiency vaccines produced in baculovirus and their use against feline immunodeficiency virus infection. ZA964680B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/481,700 US5849303A (en) 1995-06-07 1995-06-07 Recombinant feline Immunodeficiency virus subunit vaccines employing baculoviral-expressed envelope glycoproteins derived from isolate NCSU-1 and their use against feline immunodeficiency virus infection

Publications (1)

Publication Number Publication Date
ZA964680B true ZA964680B (en) 1997-12-05

Family

ID=23913018

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9604680A ZA964680B (en) 1995-06-07 1996-06-05 Recombinant feline immunodeficiency vaccines produced in baculovirus and their use against feline immunodeficiency virus infection.

Country Status (6)

Country Link
US (1) US5849303A (fr)
AR (1) AR003135A1 (fr)
AU (2) AU6037396A (fr)
CO (1) CO4480039A1 (fr)
WO (2) WO1996040956A1 (fr)
ZA (1) ZA964680B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7087234B1 (en) 1991-07-09 2006-08-08 Cornell Research Foundation, Inc. Recombinant multivalent viral vaccine
FR2775601B1 (fr) 1998-03-03 2001-09-21 Merial Sas Vaccins vivants recombines et adjuves
EP1668112A4 (fr) 2003-06-20 2009-04-29 Protein Sciences Corp Vecteurs d'expression d'immunogenes de sras, compositions contenant de tels vecteurs ou leurs produits d'expression, procedes et dosages pour leur production et leur utilisation
WO2006011919A1 (fr) * 2004-06-30 2006-02-02 Idexx Laboratories, Inc. Procédé et appareil servant à détecter le virus de l'immunodéficience féline
US7201903B2 (en) * 2003-09-11 2007-04-10 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
US7285272B2 (en) * 2003-12-18 2007-10-23 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
DE602005027326D1 (de) * 2004-02-19 2011-05-19 Idexx Lab Inc Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus
US7335360B2 (en) * 2004-06-30 2008-02-26 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
WO2006011917A1 (fr) * 2004-06-30 2006-02-02 Idexx Laboratories, Inc. Procédé et dispositif pour détecter un virus d'immunodéficience féline
US7291338B2 (en) * 2005-03-09 2007-11-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
US20070135826A1 (en) 2005-12-01 2007-06-14 Steve Zaver Method and apparatus for delivering an implant without bias to a left atrial appendage
JOP20190083A1 (ar) 2008-06-04 2017-06-16 Amgen Inc بولي ببتيدات اندماجية طافرة لـfgf21 واستخداماتها
UY32607A (es) 2009-05-05 2010-12-31 Amgen Inc Mutantes de fgf21 y usos del mismo
WO2011123781A1 (fr) 2010-04-02 2011-10-06 Idexx Laboratories, Inc. Détection du virus de l'immunodéficience féline
WO2015077717A1 (fr) 2013-11-25 2015-05-28 The Broad Institute Inc. Compositions et méthodes pour diagnostiquer, évaluer et traiter un cancer au moyen d'un état de méthylation d'adn
US11725237B2 (en) 2013-12-05 2023-08-15 The Broad Institute Inc. Polymorphic gene typing and somatic change detection using sequencing data
AU2014368898B2 (en) 2013-12-20 2020-06-11 Dana-Farber Cancer Institute, Inc. Combination therapy with neoantigen vaccine
US10993997B2 (en) 2014-12-19 2021-05-04 The Broad Institute, Inc. Methods for profiling the t cell repertoire
WO2016100975A1 (fr) 2014-12-19 2016-06-23 Massachsetts Institute Ot Technology Biomarqueurs moléculaires pour l'immunothérapie d'un cancer
EP3297660A2 (fr) 2015-05-20 2018-03-28 The Broad Institute Inc. Néo-antigènes partagés
TWI750122B (zh) 2015-06-09 2021-12-21 美商博德研究所有限公司 用於贅瘤疫苗之調配物及其製備方法
WO2017184590A1 (fr) 2016-04-18 2017-10-26 The Broad Institute Inc. Prédiction améliorée d'épitope hla
US11549149B2 (en) 2017-01-24 2023-01-10 The Broad Institute, Inc. Compositions and methods for detecting a mutant variant of a polynucleotide
US20210382068A1 (en) 2018-10-02 2021-12-09 Dana-Farber Cancer Institute, Inc. Hla single allele lines
WO2020131586A2 (fr) 2018-12-17 2020-06-25 The Broad Institute, Inc. Méthodes d'identification de néo-antigènes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2669338A1 (fr) * 1990-11-21 1992-05-22 Centre Nat Rech Scient Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline.
US5591572A (en) * 1991-06-14 1997-01-07 St. Vincents Institute Of Medical Research Limited Detection of mammalian immunodeficiency viruses
GB9215232D0 (en) * 1992-07-17 1992-09-02 Pitman Moore Inc Vaccines
GB9215233D0 (en) * 1992-07-17 1992-09-02 Pitman Moore Inc Vaccines
GB9219936D0 (en) * 1992-09-21 1992-11-04 Pitman Moore Inc Vaccines
FR2700957B1 (fr) * 1993-01-29 1995-03-03 Seppic Sa Composition de vaccin sous-unitaire recombinant vivant et procédé de préparation.
ATE334216T1 (de) * 1994-04-29 2006-08-15 Pharmacia & Upjohn Co Llc Impstoff gegen felines immunodefizienz-virus
FR2721031B1 (fr) * 1994-06-09 1996-07-26 Centre Nat Rech Scient Fragment peptidique spécifique du virus de l'immunodéficience féline (VIF) et son utilisation comme réactif de diagnostic.

Also Published As

Publication number Publication date
WO1996040956A1 (fr) 1996-12-19
AR003135A1 (es) 1998-07-08
AU6037396A (en) 1996-12-30
CO4480039A1 (es) 1997-07-09
AU6093796A (en) 1996-12-30
WO1996040957A1 (fr) 1996-12-19
US5849303A (en) 1998-12-15

Similar Documents

Publication Publication Date Title
ZA964680B (en) Recombinant feline immunodeficiency vaccines produced in baculovirus and their use against feline immunodeficiency virus infection.
ZA964694B (en) Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection.
ZA975889B (en) HIV envelope polypeptides and vaccine.
HUP9802217A3 (en) Recombinant mva virus, and the use thereof
EP0676954A4 (fr) Leurre de virus de l'immunodeficience humaine.
BR9400651A (pt) Compósito absorvente, e peça de vestuário absorvente descartável
EP0597008A4 (en) Improved expression of influenza a m2 protein in baculovirus and uses of m2 protein.
ZA951803B (en) Recombinant viruses their preparation and their therapeutic use
AU2328397A (en) Recombinant live feline immunodeficiency virus and proviral dna vaccines
AU8918998A (en) Non-immunosuppressive cyclosporins and their use in the prevention and treatmentof hiv infection
EP0467700A3 (en) Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties
IL96647A0 (en) Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides
ZA9610721B (en) Grapevine leafroll virus proteins and their uses.
AU4556597A (en) Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
ZA936592B (en) Nutrition for persons infected with human immunodeficiency virus
EP0569862A3 (fr) Feuille médicale autocollante et préparation médicale.
ZA986421B (en) 2-[Pyrazolyl-and triazolyl-3'-oxymethylene]phenylisoxa zolones, -triazolones and - tetrazolones, their preparation and their use.
ZA964679B (en) Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection.
HU9503802D0 (en) Optically active benzothiepin derivative, its preparation and use
CZ2000522A3 (cs) Farmaceutický prostředek na bázi piperidinalkanolového antihistaminika a použití
IL112075A0 (en) Recombinant human thymopoietin proteins, their preparation and their medicinal use
EP0868196A4 (fr) Vaccin de synthese pour la protection contre l'infection par le virus de l'immunodeficience humaine
AU1825895A (en) Retroviral vaccines, vaccination and immune-therapy for retroviral infections
AU2946395A (en) Recombinant infectious laryngotracheitis virus and vaccine
IL112992A0 (en) Recombinant viruses, their preparation and their use in gene therapy